Source link : https://www.newshealth.biz/health-news/refractory-multiple-myeloma-responsive-to-immunotherapy-plus-low-dose-radiotherapy/
A third of patients with relapsed/refractory multiple myeloma responded to pembrolizumab (Keytruda) plus single-fraction radiotherapy (RT), a small clinical study showed. Results at 3 months showed that seven of 25 evaluable patients responded to the treatment and one patient had stable disease. Two patients had complete responses. Immunologic response (changes in CD8+/CD4+ cells) was associated […]
Author : News Health
Publish date : 2024-07-10 21:30:34
Copyright for syndicated content belongs to the linked Source.
Categories